Track topics on Twitter Track topics that are important to you
Advair is used in the treatment of cases of Asthma resistant to other medications, and cases of COPD, chronic bronchitis and emphysema. It is a bronchodilator, but also has anti-inflammatory actions.
Source; BioPortfolio.com and Advair.com
Add the Advair News Channel to your RSS reader;
Drug maker: GlaxoSmithKline
Indication(s): Asthma and chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema
2012 sales: $7.904 billion (£5.046 billion)